BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol. 1996

A L van Steveninck, and R Gieschke, and R C Schoemaker, and G Roncari, and B Tuk, and M S Pieters, and D D Breimer, and A F Cohen
Centre for Human Drug Research, University Hospital Leiden, The Netherlands.

1. Interaction between alcohol and bretazenil (a benzodiazepine partial agonist in animals) was studied with diazepam as a comparator in a randomized, double-blind, placebo controlled six-way cross over experiment in 12 healthy volunteers, aged 19-26 years. 2. Bretazenil (0.5 mg), diazepam (10 mg) and matching placebos were given as single oral doses after intravenous infusion of alcohol to a steady target-blood concentration of 0.5 g l-1 or a control infusion of 5% w/v glucose at 1 week intervals. 3. CNS effects were evaluated between 0 and 3.5 h after drug administration by smooth pursuit and saccadic eye movements, adaptive tracking, body sway, digit symbol substitution test and visual analogue scales. 4. Compared with placebo all treatments caused significant decrements in performance. Overall, the following sequence was found for the magnitude of treatment effects: bretazenil+alcohol > diazepam+alcohol > or = bretazenil > diazepam > alcohol > placebo. 5. There were no consistent indications for synergistic, supra-additive pharmacodynamic interactions between alcohol and bretazenil or diazepam. 6. Bretazenil with or without alcohol, and diazepam+alcohol had marked effects. Because subjects were often too sedated to perform the adaptive tracking test and the eye movement tests adequately, ceiling effects may have affected the outcome of these tests. 7. No significant pharmacokinetic interactions were found. 8. Contrary to the results in animals, there were no indications for a dissociation of the sedative and anxiolytic effects of bretazenil in man.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D011698 Pursuit, Smooth Eye movements that are slow, continuous, and conjugate and occur when a fixed object is moved slowly. Pursuits, Smooth,Smooth Pursuit,Smooth Pursuits
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004856 Postural Balance A POSTURE in which an ideal body mass distribution is achieved. Postural balance provides the body carriage stability and conditions for normal functions in stationary position or in movement, such as sitting, standing, or walking. Postural Control,Posture Balance,Posture Control,Posture Equilibrium,Balance, Postural,Musculoskeletal Equilibrium,Postural Equilibrium,Balance, Posture,Control, Postural,Control, Posture,Equilibrium, Musculoskeletal,Equilibrium, Postural,Equilibrium, Posture,Postural Controls,Posture Balances,Posture Controls,Posture Equilibriums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000286 Administration, Sublingual Administration of a soluble dosage form by placement under the tongue. Drug Administration, Sublingual,Sublingual Drug Administration,Sublingual Administration,Administration, Sublingual Drug,Administrations, Sublingual,Administrations, Sublingual Drug,Drug Administrations, Sublingual,Sublingual Administrations,Sublingual Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A L van Steveninck, and R Gieschke, and R C Schoemaker, and G Roncari, and B Tuk, and M S Pieters, and D D Breimer, and A F Cohen
Pharmacokinetic and pharmacodynamic interactions between caffeine and diazepam.
April 1986, Journal of clinical psychopharmacology,
A L van Steveninck, and R Gieschke, and R C Schoemaker, and G Roncari, and B Tuk, and M S Pieters, and D D Breimer, and A F Cohen
Pharmacodynamic and pharmacokinetic interactions between ketamine and diazepam.
January 1983, European journal of clinical pharmacology,
A L van Steveninck, and R Gieschke, and R C Schoemaker, and G Roncari, and B Tuk, and M S Pieters, and D D Breimer, and A F Cohen
Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).
December 2014, Clinical pharmacokinetics,
A L van Steveninck, and R Gieschke, and R C Schoemaker, and G Roncari, and B Tuk, and M S Pieters, and D D Breimer, and A F Cohen
Pharmacodynamic and pharmacokinetic interactions between simvastatin and diazepam in rats.
October 2017, Pharmacological reports : PR,
A L van Steveninck, and R Gieschke, and R C Schoemaker, and G Roncari, and B Tuk, and M S Pieters, and D D Breimer, and A F Cohen
Psychotropic drugs and alcohol: pharmacokinetic and pharmacodynamic interactions.
April 1984, Psychosomatics,
A L van Steveninck, and R Gieschke, and R C Schoemaker, and G Roncari, and B Tuk, and M S Pieters, and D D Breimer, and A F Cohen
Pharmacodynamic and pharmacokinetic properties of diazepam in horses.
October 1982, American journal of veterinary research,
A L van Steveninck, and R Gieschke, and R C Schoemaker, and G Roncari, and B Tuk, and M S Pieters, and D D Breimer, and A F Cohen
Cilomilast: pharmacokinetic and pharmacodynamic interactions with digoxin.
June 2001, Clinical therapeutics,
A L van Steveninck, and R Gieschke, and R C Schoemaker, and G Roncari, and B Tuk, and M S Pieters, and D D Breimer, and A F Cohen
Pharmacokinetic and pharmacodynamic interaction study of diazepam and metoprolol.
January 1984, European journal of clinical pharmacology,
A L van Steveninck, and R Gieschke, and R C Schoemaker, and G Roncari, and B Tuk, and M S Pieters, and D D Breimer, and A F Cohen
Ecstasy: pharmacodynamic and pharmacokinetic interactions.
January 2004, Psychosomatics,
A L van Steveninck, and R Gieschke, and R C Schoemaker, and G Roncari, and B Tuk, and M S Pieters, and D D Breimer, and A F Cohen
Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants.
January 1976, Drugs,
Copied contents to your clipboard!